Does FILGOTINIB Cause Interstitial lung disease? 14 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with FILGOTINIB. This represents 5.9% of all adverse event reports for FILGOTINIB.
14
Reports of Interstitial lung disease with FILGOTINIB
5.9%
of all FILGOTINIB reports
3
Deaths
14
Hospitalizations
How Dangerous Is Interstitial lung disease From FILGOTINIB?
Of the 14 reports, 3 (21.4%) resulted in death, 14 (100.0%) required hospitalization, and 11 (78.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGOTINIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does FILGOTINIB Cause?
Rheumatoid arthritis (31)
Covid-19 (26)
Urinary tract infection (21)
Diarrhoea (20)
Drug ineffective (20)
Atrial fibrillation (19)
Synovitis (19)
Colitis ulcerative (18)
Nasopharyngitis (17)
Osteoarthritis (17)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which FILGOTINIB Alternatives Have Lower Interstitial lung disease Risk?
FILGOTINIB vs FILGRASTIM
FILGOTINIB vs FILGRASTIM-AAFI
FILGOTINIB vs FILGRASTIM-SNDZ
FILGOTINIB vs FINASTERIDE
FILGOTINIB vs FINASTERIDE\TAMSULOSIN